Quantbot Technologies
DMK

Quantbot Technologies’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Quantbot Technologies’s Portfolio DMK Stock Details DMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-41
Closed -$14K – 1542
2017
Q3 		$14K Sell
41
-15
-27% -$5.32K ﹤0.01% 1078
2017
Q2 		$20K Buy
+56
New +$16.8K ﹤0.01% 999

Other funds holding DMK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B. Riley Financial
B. Riley Financial Los Angeles, California $434M AUM 751.56% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bard Associates
Bard Associates Chicago, Illinois $451M AUM 66.6% 1-Year Est. Return
Leisure Capital Management
Leisure Capital Management Costa Mesa, California $320M AUM 39.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Quantbot Technologies's DMK Position: Q4 2017 in Review

Quantbot Technologies sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q4 2017, closing a stake of 41 shares — an estimated $14K sold.

Quantbot Technologies first reported a position in DMK in Q2 2017 and held it in 2 quarters. The position peaked at $20K in Q2 2017. 58 funds tracked by Wall St. Rank hold DMK as of Q4 2017.

  • Quantbot Technologies reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q4 2017 after selling out during the quarter.
  • Quantbot Technologies sold 41 DMK Pharmaceuticals Corporation Common Stock shares in Q4 2017, an estimated $14K.
  • Quantbot Technologies first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q2 2017 and held it in 2 quarters.
  • Quantbot Technologies's DMK Pharmaceuticals Corporation Common Stock position peaked at $20K in Q2 2017.
  • 58 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q4 2017.

Based on Quantbot Technologies's 13F filing for Q4 2017, filed 12 Feb 2018.